Let's take a look at just how misaligned the market can be. Take for example Rockley Photonics. They have raised 100's of millions to develop a silicon photonic biometric module for wearables with interest from Apple.

Clearly they are having problems and their inability to compete in datacom should have been a lesson.

They were identified by senior POET management years ago as an inferior platform to POET when discussed on a couple of occasions. 

So Rockley, who was not able to compete in datacom, tried to take the same platform and apply it to a biometric module that will fit in a watch. The market is massive. Who would not get excited over the numbers when the choices seemed so limited (past tense).

Recall the envy here when it was a topic on this forum as Rockley raised huge dollars to support a $30million burn rate per quarter. That kind of spending is not sustainable and silicon photonics has limits to miniaturization.

Rockley peaked at $17 and now it is trading at twenty cents.  

POET’s platform is ideally suited to fit this need. 

As stated: POET’s Datacoms deployment has matured many building blocks relevant to Chip Scale Spectrometers.

So I will include my congratulations to Mazann for making such a good decision to support POET’s future growth. 

POET has excelled at producing a highly efficient and low cost optical engine platform with the ability to precisely filter a broad wavelength spectrum. The path to  provide continued development of low cost solutions across  an increasing field of applications is going to generate a lot of growth that has and will continue to outpace and eventually displace the typical costly and slow pace of silicon phonics development. iMO